Tham khảo Loteprednol

  1. 1 2 3 4 5 6 7 Haberfeld, H., ed. (2015). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag.
  2. ↑ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery (bằng tiếng Anh). John Wiley & Sons. tr. 488. ISBN 9783527607495. 
  3. 1 2 Loteprednol Professional Drug Facts.
  4. 1 2 3 Dinnendahl, V.; Fricke, U., eds. (2008). Arzneistoff-Profile (in German). 6 (22 ed.). Eschborn, Germany: Govi Pharmazeutischer Verlag. ISBN 978-3-7741-9846-3.
  5. ↑ "HIGHLIGHTS OF PRESCRIBING INFORMATION Lotemax" (PDF). 2012.
  6. ↑ Bodor, N.; Buchwald, P. (2002). "Design and development of a soft corticosteroid, loteprednol etabonate". In Schleimer, R.P.; O'Byrne, P.M.; Szefler, S.J.; Brattsand, R. (eds.). Inhaled Steroids in Asthma. Optimizing Effects in the Airways. Lung Biology in Health and Disease, Vol. 163. Marcel Dekker, New York. pp. 541–564.
  7. ↑ "Loteprednol (Professional Patient Advice)". Truy cập October 4, 2018.
  8. ↑ Pavesio, C.E.; Decory, H.H. (2008). "Treatment of ocular inflammatory conditions with loteprednol etabonate". Br J Ophthalmol. 92 (4): 455–459. doi:10.1136/bjo.2007.132621. PMID 18245274.
  9. ↑ Druzgala, P.; Hochhaus, G.; Bodor, N. (1991). "Soft drugs—10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: Loteprednol etabonate". J. Steroid Biochem. Mol. Biol. 38 (2): 149–54. doi:10.1016/0960-0760(91)90120-T. PMID 2004037.